Sign In to Follow Application
View All Documents & Correspondence

An Improved Process For Preparation Of Highly Pure Chlorpromazine

Abstract: The present invention relates to a process for the preparation of Chlorpromazine hydrochloride of structural formula I with a high degree of purity, specifically with a low content of genotoxic impurities.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
23 March 2016
Publication Number
46/2017
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application

Applicants

ENALTEC LABS PRIVATE LIMITED
17TH FLOOR, KESAR SOLITAIRE, PLOT NO.5, SECTOR-19, SANPADA, NAVI MUMBAI MAHARASHTRA, INDIA. PIN CODE: 400705

Inventors

1. MR. KODALI ESWARA RAO
ENALTEC LABS PRIVATE LIMITED, PLOT NO.W-59 A, ADDL. MIDC. AMBERNATH, DIST-THANE 421506, MAHARASHTRA, INDIA.
2. DR. ALOK PRAMOD TRIPATHI
ENALTEC LABS PRIVATE LIMITED, PLOT NO.W-59 A, ADDL. MIDC. AMBERNATH, DIST-THANE 421506, MAHARASHTRA, INDIA.
3. DR. SANJAY DASHRATH VAIDYA
ENALTEC LABS PRIVATE LIMITED, PLOT NO.W-59 A, ADDL. MIDC. AMBERNATH, DIST-THANE 421506, MAHARASHTRA, INDIA.

Specification

Documents

Application Documents

# Name Date
1 201621010157-Abstract-070521.pdf 2021-10-18
1 201621010157-FORM 2-20-03-2017.pdf 2017-03-20
2 201621010157-Amended Pages Of Specification-070521.pdf 2021-10-18
2 201621010157-FORM 2(TITLE PAGE)-20-03-2017.pdf 2017-03-20
3 201621010157-DESCRIPTION(COMPLETE)-20-03-2017.pdf 2017-03-20
3 201621010157-Claims-070521.pdf 2021-10-18
4 201621010157-Examination Report Reply Recieved-070521.pdf 2021-10-18
4 201621010157-CORRESPONDENCE-20-03-2017.pdf 2017-03-20
5 201621010157-FER.pdf 2021-10-18
5 201621010157-CLAIMS-20-03-2017.pdf 2017-03-20
6 201621010157-Form 2(Title Page)-070521.pdf 2021-10-18
6 201621010157-ABSTRACT-20-03-2017.pdf 2017-03-20
7 201621010157-Marked Copy-070521.pdf 2021-10-18
7 201621010157-FORM 5-27-03-2017.pdf 2017-03-27
8 201621010157-Power of Attorney-070521.pdf 2021-10-18
8 201621010157-CORRESPONDENCE-27-03-2017.pdf 2017-03-27
9 201621010157-US(14)-HearingNotice-(HearingDate-21-10-2021).pdf 2021-10-18
9 ABSTRACT1.jpg 2018-08-11
10 201621010157-Correspondence-200320.pdf 2020-06-11
10 201621010157-Other Patent Document-230316.pdf 2018-08-11
11 201621010157-Form 18-200320.pdf 2020-06-11
11 201621010157-Form 3-230316.pdf 2018-08-11
12 201621010157-Form 1-230316.pdf 2018-08-11
12 201621010157-Form 2(Title Page)-230316.pdf 2018-08-11
13 201621010157-Form 1-230316.pdf 2018-08-11
13 201621010157-Form 2(Title Page)-230316.pdf 2018-08-11
14 201621010157-Form 18-200320.pdf 2020-06-11
14 201621010157-Form 3-230316.pdf 2018-08-11
15 201621010157-Correspondence-200320.pdf 2020-06-11
15 201621010157-Other Patent Document-230316.pdf 2018-08-11
16 201621010157-US(14)-HearingNotice-(HearingDate-21-10-2021).pdf 2021-10-18
16 ABSTRACT1.jpg 2018-08-11
17 201621010157-Power of Attorney-070521.pdf 2021-10-18
17 201621010157-CORRESPONDENCE-27-03-2017.pdf 2017-03-27
18 201621010157-Marked Copy-070521.pdf 2021-10-18
18 201621010157-FORM 5-27-03-2017.pdf 2017-03-27
19 201621010157-Form 2(Title Page)-070521.pdf 2021-10-18
19 201621010157-ABSTRACT-20-03-2017.pdf 2017-03-20
20 201621010157-FER.pdf 2021-10-18
20 201621010157-CLAIMS-20-03-2017.pdf 2017-03-20
21 201621010157-Examination Report Reply Recieved-070521.pdf 2021-10-18
21 201621010157-CORRESPONDENCE-20-03-2017.pdf 2017-03-20
22 201621010157-DESCRIPTION(COMPLETE)-20-03-2017.pdf 2017-03-20
22 201621010157-Claims-070521.pdf 2021-10-18
23 201621010157-FORM 2(TITLE PAGE)-20-03-2017.pdf 2017-03-20
23 201621010157-Amended Pages Of Specification-070521.pdf 2021-10-18
24 201621010157-FORM 2-20-03-2017.pdf 2017-03-20
24 201621010157-Abstract-070521.pdf 2021-10-18

Search Strategy

1 SearchStrategyof201621010157E_11-11-2020.pdf